Immunogenicity and safety of early vaccination with two doses of a combined measles-mumps-rubella-varicella vaccine in healthy Indian children from 9 months of age: a phase III, randomised, non-inferiority trial

OBJECTIVE: This study (NCT00969436) compared the immunogenicity and safety of measles-mumps-rubella (MMR) followed by MMR+varicella (V) vaccines to (1) 2 doses of combined MMRV and (2) MMR followed by MMRV, in Indian children. DESIGN: Phase III, open, randomised, non-inferiority study. SETTING: 6 te...

Descripción completa

Detalles Bibliográficos
Autores principales: Lalwani, Sanjay, Chatterjee, Sukanta, Balasubramanian, Sundaram, Bavdekar, Ashish, Mehta, Shailesh, Datta, Sanjoy, Povey, Michael, Henry, Ouzama
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Paediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567664/
https://www.ncbi.nlm.nih.gov/pubmed/26362659
http://dx.doi.org/10.1136/bmjopen-2014-007202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567664/
https://www.ncbi.nlm.nih.gov/pubmed/26362659
http://dx.doi.org/10.1136/bmjopen-2014-007202

Ejemplares similares